TY - JOUR
T1 - Tuning the Endocytosis Mechanism of Zr-Based Metal-Organic Frameworks through Linker Functionalization
AU - Orellana-Tavra, Claudia
AU - Haddad, Salame
AU - Marshall, Ross J.
AU - Abánades Lázaro, Isabel
AU - Boix, Gerard
AU - Imaz, Inhar
AU - Maspoch, Daniel
AU - Forgan, Ross S.
AU - Fairen-Jimenez, David
PY - 2017/10/18
Y1 - 2017/10/18
N2 - © 2017 American Chemical Society. A critical bottleneck for the use of metal-organic frameworks (MOFs) as drug delivery systems has been allowing them to reach their intracellular targets without being degraded in the acidic environment of the lysosomes. Cells take up particles by endocytosis through multiple biochemical pathways, and the fate of these particles depends on these routes of entry. Here, we show the effect of functional group incorporation into a series of Zr-based MOFs on their endocytosis mechanisms, allowing us to design an efficient drug delivery system. In particular, naphthalene-2,6-dicarboxylic acid and 4,4′-biphenyldicarboxylic acid ligands promote entry through the caveolin-pathway, allowing the particles to avoid lysosomal degradation and be delivered into the cytosol and enhancing their therapeutic activity when loaded with drugs.
AB - © 2017 American Chemical Society. A critical bottleneck for the use of metal-organic frameworks (MOFs) as drug delivery systems has been allowing them to reach their intracellular targets without being degraded in the acidic environment of the lysosomes. Cells take up particles by endocytosis through multiple biochemical pathways, and the fate of these particles depends on these routes of entry. Here, we show the effect of functional group incorporation into a series of Zr-based MOFs on their endocytosis mechanisms, allowing us to design an efficient drug delivery system. In particular, naphthalene-2,6-dicarboxylic acid and 4,4′-biphenyldicarboxylic acid ligands promote entry through the caveolin-pathway, allowing the particles to avoid lysosomal degradation and be delivered into the cytosol and enhancing their therapeutic activity when loaded with drugs.
KW - drug delivery
KW - endocytosis
KW - metabolic pathways
KW - metal-organic frameworks
U2 - https://doi.org/10.1021/acsami.7b07342
DO - https://doi.org/10.1021/acsami.7b07342
M3 - Article
SN - 1944-8244
VL - 9
SP - 35516
EP - 35525
JO - ACS applied materials & interfaces
JF - ACS applied materials & interfaces
IS - 41
ER -